跳至主要内容
临床试验/CTRI/2023/04/051931
CTRI/2023/04/051931已完成4 期

A Open label Clinical Study to Evaluate the Efficacy and Safety of URAL Tablet in Urolithiasis

Vasu Research Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subject with Urolithiasis as diagnosed by clinical with calculi measuring < 10mm. Hematologic and Biochemical parameters within normal limits (Study specific parameters: calcium, uric acid cannot be more than 2 times upper limit of normal value).
  • 2. Aged between =18 to = 50 years.
  • 3. Subjects willing to sign informed consent and follow the study
  • procedure and instructions.
  • 4. Subjects who are diagnosed of diabetes mellitus, whose blood
  • glucose level is under good control with consumption of
  • Anti-hyperglycemic medications and the Random Blood Sugar
  • (RBS) reading is = 200mg/dl during the screening period, can
  • be included in the study.

排除标准

  • 1. Subjects with severe obstructive uropathy, those with serious
  • systemic medical disorder- uncontrolled hypertension and
  • diabetes mellitus, other metabolic disorders, endocrinal
  • disorders and cardiac illness.
  • 2. The subjects not to have used any drugs, for at least 1 week
  • prior to the study for concurrent illness with diabetes and
  • Hypertension.
  • 3. Subjects with a strong history of food or drug allergy of any

研究者

发起方
Vasu Research Centre

相似试验